Skip to search formSkip to main contentSkip to account menu

etofibrate

Known as: 2-(p-chlorophenoxy)-2-methylpropionic acid 2- (nicotinoyloxy)ethyl ester 
An orally-available combination of clofibrate and niacin linked together by an ester bond. In the body clofibrate and niacin separate, acting as a… 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (3)

Anticholesteremic AgentsClofibric AcidHypolipidemic Agents

Narrower (1)

Lipo-Merz
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia
SummaryTwo trials have been performed in the same patients with hyperlipoproteinaemia Types IIb (12 cases), III (6 cases) and IV… 
2002
2002
Mass spectrometric monitoring of the degradation and elimination efficiency for hardly eliminable and hardly biodegradable polar compounds by membrane bioreactors.
Wastewaters containing or spiked with polar compounds--alkylphenolethoxylates (APEOs) and drugs--were treated in membrane… 
Review
2001
Review
2001
New chemical structures of hypolipidemic and antiplatelet activity
Abstract Elevated lipid level is supposed to be one of the main risk factors of atherosclerosis and subsequent cardiovascular… 
1995
1995
Biliary lipids, lithogenic index and biliary drug concentrations during etofibrate and bezafibrate treatment
SummaryHypolipidemic drugs like etofibrate and bezafibrate may induce lithogenic bile and increase the risk of gallstone… 
1994
1994
[Regression of hard exudates in diabetic background retinopathy in therapy with etofibrate antilipemic agent].
BACKGROUND The aim of this pilot study was to investigate the influence of a lipid lowering therapy with etofibrate on the… 
1990
1990
Effect of etofibrate on the development and the regression of atheromas in a rabbit model of atherosclerosis.
  • E. BetzG. Quack
  • VASA. Zeitschrift fur Gefasskrankheiten
  • 1990
  • Corpus ID: 24937337
The study presents the effect of 2-[2-(p-Chlorophenoxy)-2-methylproprionoxy]ethyl nicotinate (Etofibrate, Lipo-Merz) on… 
1987
1987
Hyperaggregability of Platelets in Patients with Hyperlipoproteinemia Type IIb Under Treatment with Etofibrate Retard and Acetylsalicylic Acid
Heightened platelet function is suggested to be associated with the well-known thrombotic complications and the accelerated… 
1986
1986
Effect of etofibrate and its metabolites on atheromas of rabbits and on smooth muscle cell cultures.
In rabbits electrodes were implanted on either side of a carotid artery wall in a way such that transmural electrical stimulation… 
1985
1985
Mitochondrial myopathy —A result of clofibrate/etofibrate treatment?
SummaryA 66-year-old man had developed a myopathy while undergoing several periods of etofibrate and clofibrate therapy over the… 
1975
1975
[Etofibrate and clofibrate in a double-blind trial on patients with raised serum-lipid levels (author's transl)].
In a clinical trial of 21 patients with hypercholesteraemia and (or) hypertriglyceridaemia, the effects of etofibrate and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)